Literature DB >> 11070032

Interaction between herpes simplex virus type 1 IE63 protein and cellular protein p32.

H E Bryant1, D A Matthews, S Wadd, J E Scott, J Kean, S Graham, W C Russell, J B Clements.   

Abstract

The herpes simplex virus type 1 (HSV-1) immediate-early gene IE63 (ICP27), the only HSV-1 regulatory gene with a homologue in every mammalian and avian herpesvirus sequenced so far, is a multifunctional protein which regulates transcriptional and posttranscriptional processes. One of its posttranscriptional effects is the inhibition of splicing of viral and cellular transcripts. We previously identified heterogeneous nuclear ribonucleoprotein (hnRNP) K and casein kinase 2 (CK2) as two protein partners of IE63 (H. Bryant et al., J. Biol. Chem. 274:28991-28998, 1999). Here, using a yeast two-hybrid assay, we identify another partner of IE63, the cellular protein p32. Confirmation of this interaction was provided by coimmunoprecipitation from virus-infected cells and recombinant p32 binding assays. A p32-hnRNP K-CK2 complex, which required IE63 to form, was isolated from HSV-1-infected cells, and coimmunoprecipitating p32 was phosphorylated by CK2. Expression of IE63 altered the cytoplasmic distribution of p32, with some now colocalizing with IE63 in the nuclei of infected and transfected cells. As p32 copurifies with splicing factors and can inhibit splicing, we propose that IE63 together with p32, possibly with other IE63 partner proteins, acts to disrupt or regulate pre-mRNA splicing. As well as contributing to host cell shutoff, this effect could facilitate splicing-independent nuclear export of viral transcripts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070032      PMCID: PMC113237          DOI: 10.1128/jvi.74.23.11322-11328.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing.

Authors:  J E Mermoud; P Cohen; A I Lamond
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

2.  In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32.

Authors:  T O Tange; T H Jensen; J Kjems
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

3.  Converting a eukaryotic transcriptional inhibitor into an activator.

Authors:  J Ma; M Ptashne
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

4.  Regulation of herpes simplex virus poly (A) site usage and the action of immediate-early protein IE63 in the early-late switch.

Authors:  F McGregor; A Phelan; J Dunlop; J B Clements
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Description of an IL-1-responsive kinase that phosphorylates the K protein. Enhancement of phosphorylation by selective DNA and RNA motifs.

Authors:  I Van Seuningen; J Ostrowski; K Bomsztyk
Journal:  Biochemistry       Date:  1995-04-25       Impact factor: 3.162

6.  Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect.

Authors:  W R Hardy; R M Sandri-Goldin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes.

Authors:  G Dubin; I Frank; H M Friedman
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection.

Authors:  M A Hardwicke; R M Sandri-Goldin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Open reading frame P--a herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA.

Authors:  R Bruni; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies.

Authors:  M Ackermann; D K Braun; L Pereira; B Roizman
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

View more
  22 in total

1.  The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32.

Authors:  Kersten T Hall; Mathew S Giles; Michael A Calderwood; Delyth J Goodwin; David A Matthews; Adrian Whitehouse
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  In vitro and in vivo interactions between the hepatitis B virus protein P22 and the cellular protein gC1qR.

Authors:  S Lainé; A Thouard; J Derancourt; M Kress; D Sitterlin; J-M Rossignol
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Mapping of functional regions in the amino-terminal portion of the herpes simplex virus ICP27 regulatory protein: importance of the leucine-rich nuclear export signal and RGG Box RNA-binding domain.

Authors:  Joy Lengyel; Chandra Guy; Vivian Leong; Sarah Borge; Stephen A Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups.

Authors:  Moon Kyoo Jang; D Eric Anderson; Koenraad van Doorslaer; Alison A McBride
Journal:  Proteomics       Date:  2015-04-28       Impact factor: 3.984

Review 5.  Host factors in enterovirus 71 replication.

Authors:  Shin-Ru Shih; Victor Stollar; Mei-Ling Li
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

Review 6.  Investigating the biology of alpha herpesviruses with MS-based proteomics.

Authors:  Esteban A Engel; Ren Song; Orkide O Koyuncu; Lynn W Enquist
Journal:  Proteomics       Date:  2015-05-15       Impact factor: 3.984

7.  Identification of human cytomegalovirus UL84 virus- and cell-encoded binding partners by using proteomics analysis.

Authors:  Yang Gao; Kelly Colletti; Gregory S Pari
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

8.  Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.

Authors:  Reem Berro; Kylene Kehn; Cynthia de la Fuente; Anne Pumfery; Richard Adair; John Wade; Anamaris M Colberg-Poley; John Hiscott; Fatah Kashanchi
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Structure of the Trypanosoma brucei p22 protein, a cytochrome oxidase subunit II-specific RNA-editing accessory factor.

Authors:  Mareen Sprehe; John C Fisk; Sarah M McEvoy; Laurie K Read; Maria A Schumacher
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

10.  Herpes simplex virus type 1 ICP27 regulates expression of a variant, secreted form of glycoprotein C by an intron retention mechanism.

Authors:  Lenka Sedlackova; Keith D Perkins; Joy Lengyel; Anna K Strain; Vicky L van Santen; Stephen A Rice
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.